The transradial access market size in 2021 stood at US$ 1.77 billion and is projected to reach US$ 3.46 billion by 2031 from US$ 1.95 billion in 2023. The market is expected to register a CAGR of 7.4% during 2023–2031. Miniaturization of transradial access equipment is likely to remain key trends in the market.
The transradial access devices market is expanding as more people prefer interventional procedures that involve radial artery access. Also, the prevalence of cardiovascular disease related to lifestyle disorders rises, the growing use of radial access devices in pediatric patients, increasing prevalence of obesity & lifestyle diseases, and rising inclination for interventional procedures using radial artery access are driving the transraidial access market.
Transraidial access is used to perform coronary angiography and percutaneous coronary intervention, which lowers the risk of vascular and bleeding complications. Catheters, guidewires, and hemostasis devices and accessories are the most regularly used products. As compared to conventional transfemoral access, transradial access usually has a lower risk of problems and less discomfort. The transradial procedures were introduced to improve patient comfort and safety. Moreover, transradial access operations are typically associated with shorter hospital stays and faster healing times.
Vascular access is usually needed in hospitalized children for a variety of clinical indications. This requirement may range from short-term or temporary needs to long-term or even permanent access. Various options for vascular access are available to the physician who cares for children to meet the required treatment needs.
The use of radial access in children undergoing PCI can be safe, effective, and comfortable with marginal radiation exposure and may offer a safety advantage as compared to femoral access in infant patient population. There are various types of kits that are available specific to arterial cannulation that comprise a catheter situated over a wire for fast and easy insertion. There is a 20-ga catheter which is an adequate size for older children and adults, and a 22-ga catheter which is preferred for pediatrics and infants.
The introduction of novel devices and technology specifically designed for transradial access improves the feasibility and success rate of peripheral therapies. For instance, longer shaft lengths in devices, as well as developments in radial intervention equipment, can improve the treatment of distant lesions by making it easier for operators to access and treat difficult anatomy. Furthermore, developing smaller profile covered stents will expand treatment options and improve procedural safety.
Key segments that contributed to the derivation of the transradial access market analysis are product, application, and end user.
The geographic scope of the transradial access market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the market. Nearly 1.2 million US populace is living with Parkinson’s disease; it is the second most common neurodegenerative disorder after Alzheimer’s. Due to prevalence of chronic disorders and the presence of supportive government plans for the development of research regarding transradial access, North America held the largest share in 2023.
The regional trends and factors influencing the Transradial Access Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Transradial Access Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 1.95 Billion |
| Market Size by 2031 | US$ 3.46 Billion |
| Global CAGR (2023 - 2031) | 7.4% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Transradial Access Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Transradial Access Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The transradial access market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the transradial access market are listed below:
The “Transradial Access Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
7.4% is the expected CAGR of the intermittent catheters market.
The use of miniature transradial access devices is likely to act as future trend for the transradial access market.
The estimated value of the transradial access market by 2031 will be US$ 3.46 billion.
The rising inclination for interventional procedures using radial artery access, increasing prevalence of obesity & lifestyle diseases, and growing use of radial access devices in pediatric patients are the driving factors impacting the transradial access market.
The North America region dominated the transradial access market in 2023.